Mednet Logo

Clinical journal of the American Society of Nephrology : CJASN 2019 Nov 18

Genetic Testing for Genetic Variants in Clinical Practice: Finally Starting to Arrive.

View Paper

Related Questions

When do you recommend testing for APOL1 variants in patients with proteinuric chronic kidney disease?

2 Answers
Mednet Member
Mednet Member
Nephrology · Columbia University

As yet, despite APOL1 being a clear risk factor for kidney disease and ESKD, there are no clear guidelines to assist in decision-making regarding genetic testing. This is mainly due to the fact that there are (as yet) no specific drugs for APOL1-mediated kidney disease. There is an RCT for inaxaplin...